Completed

Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior: A Treatment Development Study

What is being tested

MBCT+SPI

Behavioral

Who is being recruted

Behavior+1

+ Behavioral Symptoms

+ Depression

From 18 to 65 Years

+7 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 1

Interventional

Study Start: March 2013

See protocol details

Summary

Principal SponsorNew York State Psychiatric Institute

Last updated: December 4, 2015

Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2013

Actual date on which the first participant was enrolled.

The study is a nine-week clinical trial combining Safety Planning Intervention plus Mindfulness-Based Cognitive Therapy for patients with a recent history of suicidal thoughts or behavior and current or past depressive symptoms. These treatments work for depression and some preliminary data suggest they may work to prevent suicidal behavior. Participation includes: Nine weeks of free treatment Clinical assessments An opportunity to offer your views on treatment and suggestions for improving the treatment in focus groups

NCT01826240

Principal SponsorNew York State Psychiatric Institute

Last updated: December 4, 2015

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorBehavioral SymptomsDepressionSelf-Injurious Behavior

Criteria

4 inclusion criteria required to participate

18-65

History of depression

In active treatment (e.g., receiving psychiatric medications)

Suicidal behavior or thoughts (i.e., current suicidal thoughts at screening and history of at least one suicide attempt or suicide-related behavior (aborted or interrupted suicide attempt) or suicidal ideation with plan or method in the past 6 months)

3 exclusion criteria prevent from participating

Current mania, psychosis, Obsessive-Compulsive Disorder, Traumatic Brain Damage, Organic or Acute Brain Syndrome, Mental Retardation or pervasive developmental disorder

Inability to complete psychiatric interview or group treatment due to lack of cooperation or lack of comprehension

Requires priority treatment for an acute illness or debilitating problem such as severe primary substance dependence or anorexia nervosa

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group

Treatment Groups

Group I

Experimental

Note: There is only one condition in this study. Mindfulness-Based Cognitive Therapy (MBCT) is combined with Safety Planning Intervention (SPI). All individuals who choose to participate will receive MBCT+SPI.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Columbia University/New York State Psychiatric Institute

New York, United StatesOpen Columbia University/New York State Psychiatric Institute in Google Maps

CompletedOne Study Center